Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acolbifene for Breast Cancer Prevention
NCT00853996Phase 2Completed
- Sponsor
- University of Kansas Medical Center
- Start
- Feb 2009
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of acolbifene in breast cancer, sponsored by University of Kansas Medical Center. Started Feb 2009; status: completed.
02
Drugs
acolbifene
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00853996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00853996.